Abstract
As conventional FUra monochemotherapy with remission rates of about 20% remained disappointing, the addition of CF to FUrd heralded an important step towards an improved therapy of advanced colorectal cancer (1). In a broad phase II study we evaluated response, toxicity and survival of patients receiving combination treatment of FUra and CF, primarily in colorectal cancer. In addition we treated pts with prostatic cancer, breast cancer, gastric cancer and various other poor risk malignancies with this combination. We used two different schedules of FUrd and CF. Our data indicate improved response in colorectal cancer as compared to FUra alone and are promising in breast cancer and adenocarcinoma of unknown primary.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
D. Machover, F. Goldschmidt, P. Chollet, G. Metzger, J. Zittoun, J. Marquet, J.-M. Vandenbulcke, J.-L. Misset, L. Schwarzenberg, J.B. Fourtillan, H. Gaget, and G. Mathe: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J. Clin. Oncol 4: 685 (1986).
G.T. Budd, T.R. Fleming, R.M. Bukowski, J.D. McCracken, S.F. Rivkin, R.M. O’Bryan, S.P. Balcerzak, and J.S. Macdonald: 5-fluorouracil and folinic acid in the treatment of metastatic cancer: a randomized comparison. A southwest oncology group study, J. Clin. Oncol. 5: 272 (1987).
D. Machover, M. Timus, L. Schwarzenberg, J.-M. Vandenbulcke, J.-L. Misset, G. Mathe, D. Baume, E. Goldschmidt, and P. Chollet: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose leucovorin: an update, in: The current status of 5-fluorouracil-leucovorin calcium combination, H.W. Bruckner, and Y.M. Rustum, eds., John Wiley & Sons Inc. (1984).
P.J. Byrne, J. Treat, M. McFadden, P.S. Schein, P.V. Woolley, T.B. Huinink, and G. McVie: Therapeutic efficacy of the combination of 5-fluorouracil and high-dose leucovorin in patients with advanced colorectal carcinoma; single daily intravenous dose for five days, in: The current status of 5fluorouracil-leucovorin calcium combination, H.W. Bruckner, and Y.M. Rustum, eds., J. Wiley & Sons Inc. (1984).
J.L. Misset, M. Timus, J.M. Vandenbulcke, J. Zittoun, and G. Mathe: Treatment of advanced colorectal (CRC) and gastric adenocarcinomas (GC) with 5-FU and high dose folinic acid (FA), 3rd European Conference on Clinical Oncology and Cancer Nursing, June 16–20, abstract 412, Stockholm (1985).
S.G. Arbuck, H.O. Douglass, F. Trave, S. Milliron, M. Baroni, H. Nava, L.J. Emrich and Y.M. Rustum: A phase II trial of 5-fluorouracil and high-dose intravenous leucovorins in gastric carcinoma, J. Clin. Oncol. 5: 1150 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Becher, R. et al. (1988). 5-Fluorouracil and 5-Formyltetrahydrofolate in Advanced Malignancies. In: Rustum, Y., McGuire, J.J. (eds) The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. Advances in Experimental Medicine and Biology, vol 244. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-5607-3_24
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5607-3_24
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-5609-7
Online ISBN: 978-1-4684-5607-3
eBook Packages: Springer Book Archive